The Phase 2, Randomized, Placebo-controlled PRECEDENT Trial of SAGE-718 in Patients With Parkinson's Disease Cognitive Impairment: Clinical Trial in Progress

被引:0
|
作者
Bullock, Amy [1 ]
Koenig, Aaron [1 ]
Paumier, Katrina [1 ]
Freitag, Emily [1 ]
Wald, Jeffrey [1 ]
Park, Sola [1 ]
Quirk, Michael [1 ]
Billet, Jennifer Petrillo [1 ]
Doherty, James [1 ]
机构
[1] Sage Therapeut Inc, Cambridge, MA USA
关键词
D O I
10.1212/WNL.0000000000203649
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P2-11.005
引用
收藏
页数:3
相关论文
共 50 条
  • [1] A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Effects of SAGE-718 in Patients with Alzheimer's Disease: Study Design
    Lago, Tiffany
    Koenig, Aaron
    Johannesen, Jason
    Park, Sola
    Li, Sigui
    Freitag, Emily
    Wald, Jeffrey
    Paumier, Katrina
    Quirk, Michael
    Doherty, James
    NEUROLOGY, 2023, 100 (17)
  • [2] Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease
    Leroi, I
    Brandt, J
    Reich, SG
    Lyketsos, CG
    Grill, S
    Thompson, R
    Marsh, L
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (01) : 1 - 8
  • [3] SAGE-718 IN PARKINSON'S DISEASE MILD COGNITIVE IMPAIRMENT: RESULTS FROM THE PHASE 2 PARADIGM STUDY
    Koenig, A.
    Johannesen, J.
    Freitag, E.
    Li, S.
    Petrillo, J.
    Wald, J.
    Paumier, K.
    Quirk, M.
    Doherty, J.
    PARKINSONISM & RELATED DISORDERS, 2023, 113 : 44 - 44
  • [4] Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial
    Weintraub, Daniel
    Hauser, Robert A.
    Elm, Jordan J.
    Pagan, Fernando
    Davis, Matthew D.
    Choudhry, Azhar
    MOVEMENT DISORDERS, 2016, 31 (05) : 709 - 714
  • [5] Randomized placebo-controlled trial of zonisamide in patients with Parkinson's disease
    Murata, Miho
    Hasegawa, Kazuko
    Kanazawa, Ichiro
    Shirakura, Kenji
    Kochi, Kenji
    Shimazu, Rieko
    NEUROLOGY AND CLINICAL NEUROSCIENCE, 2016, 4 (01): : 10 - 15
  • [6] Randomized Placebo-controlled Trial of Memantine for Dementia in Parkinson's Disease
    Marsh, Laura
    Biglan, Kevin M.
    Williams, James R.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2010, 18 (03): : S78 - S79
  • [7] Randomized placebo-controlled trial of memantine for dementia in Parkinson's disease
    Marsh, L.
    Biglan, K.
    Williams, J. R.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S82 - S82
  • [8] Helicobacter pyloriEradication in Parkinson's Disease: A Randomized Placebo-Controlled Trial
    Tan, Ai Huey
    Lim, Shen-Yang
    Mahadeva, Sanjiv
    Loke, Mun Fai
    Tan, Jiun Yan
    Ang, Ban Hong
    Chin, Kok Ping
    Mohammad Adnan, Amni Fatihah
    Ong, Shawna Mei Chien
    Ibrahim, Aimi Izzah
    Zulkifli, Nusyaibah
    Lee, Jing Kun
    Lim, Wan Ting
    Teo, Yong Teck
    Kok, Yong Leng
    Ng, Tze Ying
    Tan, Aaron Guan Siang
    Zulkifle, Intan Maisara
    Ng, Chin Khoon
    Ee, Soon Sean
    Arafin, Shuhaina
    Mohamad Shukori, Khairunnisa
    Vadivelu, Jamunarani S.
    Marras, Connie
    Fox, Susan H.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2020, 35 (12) : 2250 - 2260
  • [9] A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease
    Kulisevsky, Jaime
    Martinez-Horta, Saul
    Campolongo, Antonia
    Pascual-Sedano, Berta
    Marin-Lahoz, Juan
    Bejr-kasem, Helena
    Labandeira-Garcia, Jose L.
    Lanciego, Jose L.
    Puig-Davi, Arnau
    Horta-Barba, Andrea
    Pagonabarraga, Javier
    Rodriguez-Antiguedad, Jon
    PARKINSONISM & RELATED DISORDERS, 2023, 110
  • [10] Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial
    Gibson, Gary E.
    Luchsinger, Jose A.
    Cirio, Rosanna
    Chen, Huanlian
    Franchino-Elder, Jessica
    Hirsch, Joseph A.
    Bettendorff, Lucien
    Chen, Zhengming
    Flowers, Sarah A.
    Gerber, Linda M.
    Grandville, Thomas
    Schupf, Nicole
    Xu, Hui
    Stern, Yaakov
    Habeck, Christian
    Jordan, Barry
    Fonzetti, Pasquale
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (03) : 989 - 1010